{
Jeffrey La Rosa

People

}
001122334455554433221100
001122334455554433221100

Janux Therapeutics Shares Soar on Promising Prostate Cancer Drug Results

Janux Therapeutics' shares soared nearly 75% after promising early-stage results for its prostate cancer drug, JANX007, which targets metastatic, castration-resistant prostate cancer. In a small trial, 16 patients showed significant reductions in prostate-specific antigens, with mild side effects reported. Analysts are optimistic about the drug's potential, raising share price targets as Janux prepares for further trials.
BioPharma Dive
United States Dollar Novartis AG Janux Therapeutics, Inc. USA Matt Phipps Jeffrey La Rosa
Healthcare, Market Report
01:00 03.12.2024
Trending
Subcategory
Corporate News Industry Trends Stock Market Updates Finance Mergers & Acquisitions Retail and Consumer Goods Global Financial Events Market Analysis and Predictions Financial Scams and Security AI Innovations Industry Mergers & Acquisitions Hedge Funds & Private Equity Global Trade Developments CEO Changes Supply Chain Management Funding Rounds & Investments Banking Regulations Startups & Entrepreneurship Workplace Trends Government Economic Policies AI & Automation Regulations
Countries:
USA CHN IND TWN CAN GBR ARE JPN DEU SAU VNM CHE SGP HKG THA KOR KHM BRA AUS MYS
Companies:
NVIDIA Corporation Barclays PLC Morgan Stanley JPMorgan Chase & Co. Tesla, Inc. Capital One Financial Corporation The Goldman Sachs Group, Inc. Bank of America Corporation Apple Inc. Wells Fargo & Company Huawei Technologies CO. Ltd. Netflix, Inc. The Charles Schwab Corporation Citigroup Inc. Tesmec S.p.A. Truist Financial Corp Google Inc. Discovery Silver Corp. Discover Financial Services Microsoft Corporation
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro British Pound Sterling Swiss Franc United Arab Emirates Dirham Canadian Dollar South Korean Won Singapore Dollar Hong Kong Dollar Vietnamese Đồng Offshore Chinese Yuan Japanese Yen Brazilian Real Colombian Peso Australian Dollar
People:
Donald Trump Elon Musk Dan Ives Jerome Powell Joe Biden Paul Triolo Jamie Dimon Raja Akram Warren Buffett Troy L Rohrbaugh Jensen Huang Raimo Lenschow Geng Ngarmboonanant Kevin Hassett Amit Sachdeva Narendra Modi Giorgio Pradelli Oliver Balmelli Vishal Goyal Mark Mason

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.